Nuwellis
Update in progressNUWE (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Nuwellis, Inc. is a medical device company focused on ultrafiltration therapy. It develops, manufactures, and sells Aquadex FlexFlow and Aquadex SmartFlow systems for treating fluid overload from heart failure. Each FlexFlow package includes a console, disposable blood circuit, and catheter. Sales are via a US direct force and international distributors. Formerly CHF Solutions, renamed in 2021, headquartered in Eden Prairie, Minnesota, and founded in 1999.
Company score
- Sentiment
- 0.07
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.00
- Governance
- 0.09
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.02
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.05
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqCM (NCM)
- LocationUnited States
- CEOMr. Michael Kendrick McCormick
- Founded1999
- Employees38
- Websitewww.nuwellis.com
Identifiers
- ISINUS67113Y6032
- FIGIBBG000QVFRH8
- CUSIP67113Y108
- CIK0001506492